CLOV
Clover Health Investments, Corp. · Healthcare · Medical - Healthcare Plans
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham +23.0% · posisi baru bersih 0.0% — formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q1 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 85 | +6 | 128.61M | $672.46M | +12 | −6 |
| Q1 2026 | 82 | +5 | 113.55M | $200.08M | +10 | −5 |
| Q4 2025 | 76 | -1 | 119.92M | $281.85M | — | −1 |
| Q3 2025 | 14 | -2 | 85.90M | $262.85M | — | −2 |
| Q2 2025 | 13 | +1 | 91.13M | $254.25M | +1 | — |
| Q1 2025 | 9 | 0 | 31.30M | $112.39M | +2 | −2 |
| Q4 2024 | 9 | 0 | 25.46M | $80.20M | — | — |
| Q3 2024 | 8 | +1 | 20.89M | $58.90M | +2 | −1 |
| Q2 2024 | 7 | — | 19.27M | $23.70M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 11.02M | -0.4% | $39.58M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 2 | Millennium Management ✦ | 5.80M | +365.9% | $20.84M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasif) | 5.03M | +3.0% | $18.07M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasif) | 5.03M | +3.0% | $18.07M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Marshall Wace ✦ | 4.58M | +21.4% | $16.43M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Marshall Wace ✦ | 4.58M | +21.4% | $16.43M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Marshall Wace ✦ | 4.58M | +21.4% | $16.43M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | State Street Global Advisors ✦ (pasif) | 2.93M | +4.6% | $10.51M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 1.73M | +90.3% | $6.23M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 1.73M | +90.3% | $6.23M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 152.50K | Baru | $548,000 | 0.0% | New | 1 | SEC ↗ |
| 12 | Gotham Asset Management ✦ | 40.93K | -4.7% | $146,928 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 13.58K | Baru | $48,738 | 0.0% | New | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 13.58K | Baru | $48,738 | 0.0% | New | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 13.58K | Baru | $48,738 | 0.0% | New | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 13.58K | Baru | $48,738 | 0.0% | New | 1 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| T. Rowe Price | $548,000 | 0.0% |
| AQR Capital Management | $48,738 | 0.0% |
| AQR Capital Management | $48,738 | 0.0% |
| AQR Capital Management | $48,738 | 0.0% |
| AQR Capital Management | $48,738 | 0.0% |
Telah keluar
| Two Sigma Investments | $1.59M | adalah 0.0% |
| Point72 Asset Management | $747,180 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 207 pemegang, 127.13M saham, $218.62M dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 17.77K lbr · $78,032
Officer, Director · 87.80K lbr · $408,261
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi